154
Participants
Start Date
January 31, 2010
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
Everolimus
Everolimus 10 mg. Taken orally, every evening, 1 hr before or 2 hrs after meals
BNC105P
BNC105P, up to 16 mg/m\^2
Prince of Wales Hospital, Randwick
Royal Prince Alfred Hospital: Sydney Cancer Centre, Camperdown
Sydney Adventist Hospital Ltd., Wahroonga
Alfred Hospital, Melbourne
Austin Hospital, Heidelberg
Peninsula Oncology Centre, Frankston
Royal Brisbane & Women's Hospital, Herston
Gallipoli Medical Research Foundation: Greenslopes Private Hospital, Greenslopes
Princess Alexandra Hospital, Woolloongabba
Royal Adelaide Hospital, Adelaide
Ashford Cancer Centre, Kurralta Park
Royal Perth Hospital, Perth
Gallipoli Medical Research Foundation: Launceston General Hospital, Launceston
Tisch Cancer Institute at Mount Sinai Medical Center, New York
Hematology Oncology Associates of Rockland, Nyack
NYU Langone Arena Oncology, Lake Success
New York Oncology Hematology, PC, Albany
Roswell Park Cancer Institute, Buffalo
Allegheny Cancer Center, Pittsburgh
Mount Nittany Medical Center, State College
Gettysburg Cancer Center, Gettysburg
Geisinger Medical Center, Danville
Berks Hematology Oncology Associates, West Reading
Lynchburg Hematology Oncology Clinic, Inc., Lynchburg
First Health of the Carolinas, Pinehurst
MUSC Hollings Cancer Center, Charleston
South Carolina Cancer Specialists, Hilton Head Island
Northeast Georgia Cancer Care, LLC, Athens
Dublin Hematology & Oncology Care, Dublin
Cancer Specialists of North Florida, Jacksonville
University of Florida, Shands Cancer Center, Gainesville
Cancer Care Centers of Brevard, Rockledge
Advanced Pharma CR, LLC, Miami
Broward Oncology Associates, Fort Lauderdale
Ocala Cancer Institute, Ocala
Cancer Care Centers of Florida: Brooksville, Brooksville
Cancer Care Centers of Florida, New Port Richey
Northwest Alabama Cancer Center, Muscle Shoals
The Jones Clinic, PC, Germantown
Kentucky Cancer Clinic, Hazard
Purchase Cancer Group, Paducah
Lawrence M. Stallings, M.D., Wooster
Signal Point Clinical Research Center, Middletown
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
IU Health Central Indiana Cancer Centers, Indianapolis
Community Regional Cancer Center, Indianapolis
Monroe Medical Associates, Munster
IU Health Goshen, Goshen
Northern Indiana Cancer Research Consortium, South Bend
Fort Wayne Oncology & Hematology, Inc, Fort Wayne
IU Health at Ball Memorial Hospital Cancer Center, Muncie
Oncology Hematology Associates of SW Indiana, Newburgh
Deaconess Clinic, Evansville
Horizon Oncology Research, Lafayette
St. Joseph Mercy Hospital, Ann Arbor
Metro Health Cancer Care, Wyoming
Cancer and Hematology Centers of Western Michigan, Grand Rapids
Siouxland Hematology Oncology Associates, LLP, Nylen Cancer Center, Sioux City
University of Wisconsin, Clinical Cancer Center, Milwaukee
Mayo Clinic, Rochester
Sletten Cancer Specialists, Great Falls
Bozeman Deaconness Cancer Center, Bozeman
Edward H. Kaplan, M.D., & Associates, Skokie
Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago
Medical & Surgical Specialists, LLC, Galesburg
Cancer Center of Kansas, Wichita
Methodist Cancer Center, Omaha
Metairie Oncologists, Metairie
Medical Oncology LLC, Baton Rouge
Genesis Cancer Center, Hot Springs
Mercy Physicians Of Oklahoma, Oklahoma City
Texas Oncology, PA, Dallas
Texas Oncology: Bedford, Bedford
Texas Oncology: Fort Worth, Fort Worth
Texas Oncology: Houston Memorial City, Houston
Methodist Hospital Research Institute, Houston
Houston Cancer Center, Houston
CTRC at The UT Health Science Center at San Antonio, San Antonio
Texas Oncology: Austin North, Austin
Joe Arrington Cancer Research and Treatment Center, Lubbock
Centura Health Research Center, Denver
Western Oncology & Hematology, Golden
Kootenai Cancer Center, Post Falls
Presbyterian Medical Group, Albuquerque
University of New Mexico Cancer Center: Albuquerque, Albuquerque
Good Samaritan Hospital, Los Angeles
UCLA Med - Hematology & Oncology, Los Angeles
American Institute of Research, Whittier
City of Hope, Duarte
Providence Health System: Roy and Patricia Disney Family Cancer Center, Burbank
Compassionate Cancer Care Medical Group, Riverside
Robert A. Moss, M.D., FACP, Inc., Fountain Valley
Compassionate Cancer Care Medical Group, Inc., Corona
Compassionate Cancer Care Medical Group, Corona
California Cancer Associates for Research and Excellence, Fresno
Marin Specialty Care, Greenbrae
Willamette Valley Cancer Institute, Springfield
Cascade Cancer Center, Kirkland
Group Health Medical Centers, Seattle
University of Washington, Seattle Cancer Care Alliance, Seattle
Harrison HealthPartners Bremerton Hematology & Oncology, Bremerton
Rockwood Clinic, Spokane
National Cancer Centre Singapore, Singapore
Tufts Medical Center, Boston
Dartmouth-Hitchcock Medical Center, Manchester
Trinitas Regional Medical Center, Elizabeth
Somerset Hematology Oncology Associates, Somerville
Hematology and Oncology Associates of Rhode Island, Cranston
Lead Sponsor
Collaborators (1)
Bionomics Limited
INDUSTRY
Hoosier Cancer Research Network
OTHER